Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease.

July 9 (UPI) -- A common virus once thought harmless to humans might be linked to Parkinson's disease, a new study says. The ...

A progressive neurological disorder affecting 10 million people globally, Parkinson’s can cause disruptive symptoms such as ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Kerry Huntington counts out loud each punch she hurls at the speed bag in front of her, keeping her eyes trained on the ...

Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

For Oak Cliff native Katherine Craft, the new audio comedy series Shaky is personal. The writer-director’s nine-episode ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?